Xenon Pharmaceuticals

(NASDAQ) XENE

Current Price$56.12

Market Cap$5.32B

Since IPO (2014)+431%

5 Year+204%

1 Year+45%

1 Month+0%

Xenon Pharmaceuticals Financials at a Glance

Market Cap

$5.32B

Revenue (TTM)

$7.50M

Net Income (TTM)

$345.91M

EPS (TTM)

$-4.36

P/E Ratio

-12.79

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$56.12

Volume

54,187

Open

$55.90

Price

$56.12

Volume

54,187

Open

$55.90

Previous Close

$56.12

Daily Range

$55.21 - $56.57

52-Week Range

$28.19 - $63.95

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$56.12

Volume

54,187

Open

$55.90

Previous Close

$56.12

Daily Range

$55.21 - $56.57

52-Week Range

$28.19 - $63.95

XENE News

Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know

Jonathan PoncianoMar 27, 2026

This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough

Jonathan PoncianoMar 13, 2026

Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data

Jonathan PoncianoFeb 19, 2026

investment-advisor-pitching-stocks-to-buy-getty

Page 1

XENE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xenon Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

370

CEO

Ian C. Mortimer, MBA

Website

www.xenon-pharma.com

Headquarters

Burnaby, BC V5G 4W8, CA

XENE Financials

Key Financial Metrics (TTM)

Gross Margin

-9%

Operating Margin

-50%

Net Income Margin

-46%

Return on Equity

-52%

Return on Capital

-40%

Return on Assets

-35%

Earnings Yield

-7.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.32B

Shares Outstanding

95.43M

Volume

54.19K

Avg. Volume

1.36M

Financials (TTM)

Gross Profit

$4.96M

Operating Income

$373.07M

EBITDA

$342.35M

Operating Cash Flow

$279.12M

Capital Expenditure

$799.00K

Free Cash Flow

$279.92M

Cash & ST Invst.

$548.89M

Total Debt

$7.94M

Xenon Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$611.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$5.32B

N/A

Market Cap/Employee

$16.84M

N/A

Employees

316

N/A

Net Income

$105.26M

-60.3%

EBITDA

$104.11M

-35.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$540.94M

-12.5%

Accounts Receivable

$1.37M

-6.7%

Inventory

$0.00

N/A

Long Term Debt

$6.41M

-16.1%

Short Term Debt

$1.53M

+11.9%

Return on Assets

-35.24%

N/A

Return on Invested Capital

-39.69%

N/A

Free Cash Flow

$81.80M

-48.3%

Operating Cash Flow

$81.48M

-49.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SRRKScholar Rock Holding Corporation

SRRKScholar Rock Holding Corporation$46.61+0.67%

CGONCG Oncology, Inc. Common stock

CGONCG Oncology, Inc. Common stock$66.74+3.07%

CELCCelcuity Inc.

CELCCelcuity Inc.$121.35+1.97%

CNTACentessa Pharmaceuticals plc

CNTACentessa Pharmaceuticals plc$39.42-0.08%

APGEApogee Therapeutics, Inc.

APGEApogee Therapeutics, Inc.$82.89+1.05%

LEGNLegend Biotech Corporation

LEGNLegend Biotech Corporation$23.52+3.29%

TVTXTravere Therapeutics, Inc.

TVTXTravere Therapeutics, Inc.$42.12+5.04%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$94.48-0.00%

NOKNokia

NOKNokia$12.91+0.04%

AMZNAmazon

AMZNAmazon$265.06+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

FFord Motor Company

FFord Motor Company$12.08-0.01%

Questions About XENE

What is the current price of Xenon Pharmaceuticals?

Xenon Pharmaceuticals is trading at $56.12 per share.

What is the 52-week range for Xenon Pharmaceuticals?

Over the past 52 weeks, Xenon Pharmaceuticals has traded between $28.19 and $63.95.

How much debt does Xenon Pharmaceuticals have?

As of the most recent reporting period, Xenon Pharmaceuticals reported total debt of $7.94M.

How much cash does Xenon Pharmaceuticals have on hand?

Xenon Pharmaceuticals reported $199.16M in cash and cash equivalents in its most recent financial results.

What is Xenon Pharmaceuticals’s dividend yield?

Xenon Pharmaceuticals does not currently have a dividend yield.

Xenon Pharmaceuticals

Xenon Pharmaceuticals Financials at a Glance

XENE News

Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know

This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough

Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data

3 Growth Stocks Near 52-Week Highs to Buy Anyway

Is Xenon Pharmaceuticals a Good Stock to Buy Now?

Why Xenon Pharmaceuticals Stock Is Screaming Higher Today

Is Now a Good Time To Buy Neurocrine Biosciences?

3 High-Risk, High-Reward Stocks That Have Massive Upside Potential

XENE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Xenon Pharmaceuticals

XENE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Xenon Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About XENE

What is the current price of Xenon Pharmaceuticals?

What is the 52-week range for Xenon Pharmaceuticals?

How much debt does Xenon Pharmaceuticals have?

How much cash does Xenon Pharmaceuticals have on hand?

What is Xenon Pharmaceuticals’s dividend yield?

Premium Investing Services